Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,106 | -10,348 | -26,754 | -15,072 | -8,917 |
| Depreciation Amortization | 208 | 166 | 570 | 405 | 275 |
| Income taxes - deferred | N/A | N/A | -164 | N/A | N/A |
| Accounts receivable | N/A | N/A | 12,511 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 764 | N/A | N/A |
| Other Working Capital | -6,749 | -5,918 | 21,893 | 19,370 | 28,584 |
| Other Operating Activity | 2,806 | 992 | -9,886 | 3,289 | 2,409 |
| Operating Cash Flow | $-25,841 | $-15,108 | $-1,066 | $7,992 | $22,351 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,054 | -121 | -1,698 | -1,133 | -808 |
| Purchase Of Investment | -26,997 | -8,037 | -117,582 | -67,015 | -67,222 |
| Sale Of Investment | 35,647 | 2,842 | 110,405 | 64,490 | 10,974 |
| Investing Cash Flow | $7,596 | $-5,316 | $-8,875 | $-3,658 | $-57,056 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 280 | N/A | 48,511 | 48,504 | 48,228 |
| Financing Cash Flow | $280 | $N/A | $48,511 | $48,504 | $48,228 |
| Exchange Rate Effect | -2,001 | -2,349 | -1,581 | -1,234 | -825 |
| Beginning Cash Position | 74,867 | 74,867 | 37,878 | 37,878 | 37,878 |
| End Cash Position | 54,901 | 52,094 | 74,867 | 89,482 | 50,576 |
| Net Cash Flow | $-19,966 | $-22,773 | $36,989 | $51,604 | $12,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,841 | -15,108 | -1,066 | 7,992 | 22,351 |
| Capital Expenditure | -1,054 | -121 | -1,698 | -1,133 | -808 |
| Free Cash Flow | -26,895 | -15,229 | -2,764 | 6,859 | 21,543 |